NRC Health Capitalized Contract Cost, Impairment Loss
NRC Health (NRC) reported Capitalized Contract Cost, Impairment Loss of $7.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedContractCostImpairmentLoss · last filed 2026-03-05
- NRC Health capitalized contract cost, impairment loss for the quarter ending 2025-12-31 was $5.00K, a 75.00% decline year-over-year.
- NRC Health capitalized contract cost, impairment loss for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- NRC Health capitalized contract cost, impairment loss for the quarter ending 2025-06-30 was $0.00.
- NRC Health capitalized contract cost, impairment loss for the quarter ending 2025-03-31 was $2.00K, a 94.12% decline year-over-year.
- NRC Health capitalized contract cost, impairment loss for fiscal 2025 was $7.00K, a 87.72% decline from fiscal 2024.
- NRC Health capitalized contract cost, impairment loss for fiscal 2024 was $57.00K, a 39.02% increase from fiscal 2023.
- NRC Health capitalized contract cost, impairment loss for fiscal 2023 was $41.00K, a 192.86% increase from fiscal 2022.
- NRC Health capitalized contract cost, impairment loss for fiscal 2022 was $14.00K, a 54.84% decline from fiscal 2021.
| Period end | Capitalized Contract Cost, Impairment Loss 3 month | Capitalized Contract Cost, Impairment Loss 6 month | Capitalized Contract Cost, Impairment Loss 9 month | Capitalized Contract Cost, Impairment Loss 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $5.00K derived: sum of 2 quarters · filed 2026-03-05 | $5.00K derived: sum of 3 quarters · filed 2026-03-05 | $7.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $2.00K 10-Q · filed 2025-11-07 | $22.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $2.00K 10-Q · filed 2025-08-08 | $22.00K derived: sum of 3 quarters · filed 2026-03-05 | $25.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2025-03-31 | $2.00K 10-Q · filed 2025-05-09 | $22.00K derived: sum of 2 quarters · filed 2026-03-05 | $25.00K derived: sum of 3 quarters · filed 2026-03-05 | $25.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $23.00K derived: sum of 2 quarters · filed 2026-03-05 | $23.00K derived: sum of 3 quarters · filed 2026-03-05 | $57.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $3.00K 10-Q · filed 2024-11-08 | $3.00K derived: sum of 2 quarters · filed 2024-11-08 | $37.00K 10-Q · filed 2025-11-07 | $37.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $34.00K 10-Q · filed 2025-08-08 | $34.00K derived: sum of 3 quarters · filed 2026-03-05 | $60.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $34.00K 10-Q · filed 2025-05-09 | $34.00K derived: sum of 2 quarters · filed 2026-03-05 | $60.00K derived: sum of 3 quarters · filed 2026-03-05 | $67.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $26.00K derived: sum of 2 quarters · filed 2026-03-05 | $33.00K derived: sum of 3 quarters · filed 2026-03-05 | $41.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | $26.00K 10-Q · filed 2024-11-08 | $33.00K derived: sum of 2 quarters · filed 2024-11-08 | $41.00K 10-Q · filed 2024-11-08 | $41.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $7.00K 10-Q · filed 2024-08-08 | $15.00K 10-Q · filed 2024-08-08 | $15.00K derived: sum of 3 quarters · filed 2025-03-17 | $28.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $8.00K 10-Q · filed 2024-05-09 | $8.00K derived: sum of 2 quarters · filed 2025-03-17 | $21.00K derived: sum of 3 quarters · filed 2025-03-17 | $21.40K derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $13.00K derived: sum of 2 quarters · filed 2025-03-17 | $13.40K derived: sum of 3 quarters · filed 2025-03-17 | $14.00K 10-K · filed 2025-03-17 |
| 2022-09-30 | $13.00K 10-Q · filed 2023-11-09 | $13.40K derived: sum of 2 quarters · filed 2023-11-09 | $14.00K 10-Q · filed 2023-11-09 | $21.40K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $400.00 10-Q · filed 2023-08-04 | $1.00K 10-Q · filed 2023-08-04 | $8.40K derived: sum of 3 quarters · filed 2024-02-27 | $10.40K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-05 | $8.00K derived: sum of 2 quarters · filed 2024-02-27 | $10.00K derived: sum of 3 quarters · filed 2024-02-27 | $25.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $9.00K derived: sum of 2 quarters · filed 2024-02-27 | $24.00K derived: sum of 3 quarters · filed 2024-02-27 | $31.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-04 | $17.00K derived: sum of 2 quarters · filed 2022-11-04 | $24.00K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $15.00K 10-Q · filed 2022-08-05 | $22.00K 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $7.00K 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $63.00K 10-K · filed 2023-03-03 | |||
| 2019-12-31 | $22.00K 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |